Cochlear Profit Results Up
- Bottom Ten Stocks All Ords
- Worst Australian Stockmarket Shares - All Ordinaries
- S&P All Ords Worst Performing Stocks
- Best Performers S&P All Ords
- Strong Weekly Gaining Stocks on All Ordinaries
- Stock Screener - All Ordinaries Best Stocks
- Stock Screener - ASX 200 Best Stocks
- Which Stocks Rose the Most in the Top 500 ASX All Ordinaries Shares?
- Worst Performing All Ordinaries Shares of The Week
Hearing implant systems manufacturer, Cochlear (ASX:COH) has announced a 19 percent increase in net profit at $130.5 million. The company has also announced a final dividend, which is 60 percent franked at $1.05.
- Net Profit after Tax (NPAT) of $155.2 million, up 19%.
- Successful launch of new cochlear implant system Cochlear™ Nucleus® 5 with second half CI unit sales up 20% and full year up 13% to 21,023 units
- Total revenue up 6% to $734.8 million, with sales up 12% in constant currency
- Due to 4% margin expansion EBIT up 20% to $220.5 million
- Free Cash Flow at $166 million up 50% on last year
- Final dividend of $1.05c per share (60% franked) bringing total dividends for the year to $2.00 per share, up 14% on the prior year.
Total revenues were $734.8 million, up 6%. Sales, excluding FX contracts, were $696.2 million, down 2%. In constant currency (that is restating F09 at F10 FX rates), F10 sales were up 12% compared to F09.
Cochlear implant (CI) sales which included accessories and sound processor upgrades were $603.7 million, down 2%, up 13% in constant currency.
Cochlear implant unit sales increased 13% to 21,023 units, with second half unit sales up 20% reflecting the momentum of the launch of the Nucleus 5 which commenced in the first half. This momentum meant that the majority of implants sold in the second half of F10 were Nucleus 5.
Baha sales of $92.5 million grew 9% in constant currency (down 5% in reported currency).
Regional sales reflected growth in constant currency in all regions: Americas sales of $307.6 million were up 18% in constant currency (2% in reported currency) following the Cochlear Nucleus 5 product releases. EMEA (Europe, Middle East and Africa) sales of $291.5 million were up 7% in constant currency (down 9% in reported currency). The Cochlear Nucleus 5 launch drove double digit growth in the developed countries where it was released.
Tender sales were variable and overall were down on the prior year. Asia Pacific sales of $97.1 million were up 5% and 13% in constant currency. This included 500 units sold into China for the donation program.
Expenses grew less than sales growth. SG&A fell 1% to $227.4 million (up 7% in constant currency). Research and Development expense fell 2% to $94.9 million (up 1% in constant currency). This controlled approach to expenses combined with the sales growth led to margin expansion with EBIT/Total Revenue improving 4% to 30%.
Free Cash Flow
Cash from operating activities was up 22% to a record $179.5 million. Free cash flow of $166 million was up 50%. Trade receivables of $159.5 million grew 4% over the prior year and debtors days fell to 72 days (F09 73 days). Inventory fell 1% to $104.4 million.
Cochlear’s new global headquarters building program is on track for completion by the end of the calendar year. On practical completion Macquarie University will pay Cochlear approximately $128 million and lease the building to Cochlear on commercial terms. Some $74.3 million had been spent on the building by 30th June 2010.
Total net debt was $113.9 million at 30th June 2010. Excluding $72.8 million of net debt for the new global headquarters at Macquarie University net debt at 30th June 2010 was $41.1 million. This equates to a net gearing ratio of 9% (F09, 21%) defined as (net debt / net debt + equity).
Foreign exchange movements can impact Cochlear’s financial results. In F10 the average Australian Dollar rates appreciated 16% against the USD and 15% against the Euro, compared to F09.
Gains from FX contracts were $38.6 million for the year. This offset some of the effects of an appreciating AUD, although if F09 rates had applied in F10, NPAT would have been $15.1 million more than reported (ie. $170.3 million).
A final partially franked dividend of $1.05 (franked to 60%) per share was declared and will be paid on 23rd September 2010 based on a record date of 2nd September 2010. The dividend for the year is $2.00, up 14%. The unfranked portion of the dividend has been declared Conduit Foreign Income. This is beneficial to our overseas shareholders as no withholding tax applies to the dividend.
- What Are Broker Recommendations?
- Free Tickets to Trading & Investing Seminar & Expo ($18) Brisbane 2013
- Stock Calc App
- All About Warrants
- Introduction to Exchange Traded Funds
- Introduction to Exchange Traded Funds: Features
- Introduction to Exchange Traded Funds: Domestic ETFs
- Introduction to Exchange Traded Funds: International ETFs
- Exchange Traded Commodities
- Exchange Traded Commodities: In Summary
- How much Should I Pay for an Option?
- Options Trading: Time Value
- Options Pricing
- Why You Should Trade Index Options
- How to Weather out Flat Markets Using Options
- Australian Stock Scan
- Australian Online Share Trading
- List of Trading Books
- Interesting Thoughts about the Australian Dollar
- What's the Meaning of Hawkish?
- Do You Know How To Use the P/E Ratio
- Trading, Religion and Politics - Do They Have Anything in Common?
- Shares that are Volatile that Double and Half in the Short Term
- Telstra (TLS) T3
- Margin Call by E-mail
- The Cost of Holding a Position
- Lack of Disclosure: Compensation from ASX Listed Company
- Unrealistic Returns and Benchmarks
- CMC Markets Down
- Quality versus Quantity Forex Trading
- Woolworths 1H Sales $30.7bn up 3.2%
Date added 31-01-2013
- ASIC Fines CommBank's CommSec
Date added 25-09-2012
- Industry Super Network Calls to Ban High Frequency Trading (HFT)
Date added 22-09-2012
- NAB Launches Online Share Trading Platform
Date added 19-09-2012
- Reserve Bank of Australia Says 23 Countries Holding AUD
Date added 18-09-2012
- Australia Post Digital Mailbox
Date added 10-09-2012
- Winners and Losers of Trading for Week 2
Date added 16-01-2012
- 2012's First Week of the Best and Worst Traded Stocks
Date added 09-01-2012
- 2011's Last Best and Worst Traded Stocks
Date added 05-01-2012
- Best and Worst Pre-Christmas Traded Stocks
Date added 30-12-2011
- Trading Winners and Losers for Dec. 12-16
Date added 19-12-2011
- Best and Worst Traded Stocks for Dec. 5-9
Date added 13-12-2011
- Top 3 Best and Worst Traded Stocks
Date added 05-12-2011
- ASX Glitch Trading Halt
Date added 27-10-2011
- Worst Trade Stocks (and the Best)
Date added 06-08-2011
Top 150 Public Companies Listed on the Australian Stockmarket as at 29/05/2009
- BHP Billiton
- Westpac Banking Corporation (WBC)
- Commonwealth Bank of Australia (CBA)
- National Australia Bank (NAB)
- Telstra (TLS)
- News Corporation (NWS)
- Woolworths Limited(WOW)
- Woodside Petroleum Limited (WPL)
- Rio Tinto
- Westfield Group (WDC)
- Westfarmers Limited (WES)
- QBE Insurance
- Newcrest Mining Limited (NCM)
- Origin Energy Limited (ORG)
- Santos Limited (STO)
- AMP Limited (AMP)
- Macquarie Group (MQG)
- Foster’s Group Limited (FGL)
ASX GICS Sector Company List
- Automobile & Components
- Capital Goods
- Commercial Services & Supplies
- Consumer Durables & Apparel
- Consumer Services
- Diversified Financials
- Food & Staples Retailing
- Food Beverage & Tobacco
- Health Care Equipment & Services
- Pharmaceuticals, Biotechnology & Life Sciences
- Real Estate
- Semiconductors & Semiconductor Equipment
- Software & Services
- Technology Hardware & Equipment
- Telecommunication Services